Exchange: BATS·Updated 04:00 PM EST

MDEV News

News
all
press releases
The company posted Q4 revenue of $31.5 million, marking a 41% increase year-on-year (YoY), while the adjusted loss per share (EPS) for the quarter was $0.02.
Stocktwits
The company said it anticipated its fourth-quarter (Q4) sales to fall within a tight range of $103.6 million to $103.8 million, compared with the analyst consensus estimate of $104.64 million, according to FiscalAI data.
Stocktwits
West Pharmaceutical Services has trailed behind the broader market over the past year, yet analysts remain highly optimistic, standing by its potential for a strong rebound.
barchart.com

Advertisement|Remove ads.